Advertisement

Topics

Atlas Venture Announces $350 Million Fund XI

06:30 EDT 29 Jun 2017 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
New fund will be deployed to create breakthrough biotech startups Atlas Venture, a leading early stage venture capital firm investing in groundbreaking biotech innovation, today announced the closing of its eleventh f...

Other Sources for this Article

Media Contact:
Atlas Venture
Kristen Margeson, 857-201-2700
Director of Investor Relations and Marketing
lifesciences@atlasventure.com

NEXT ARTICLE

More From BioPortfolio on "Atlas Venture Announces $350 Million Fund XI"

Quick Search
Advertisement
 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...